Physician profile
Rae Teaf
NPI 1386257806
$1,368.97
in general payments reported to CMS, 2019-2025
17 companies · $23.32 in 2025
The $23.32 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $490 · 2022: $776 · 2023: $57.07 · 2024: $22.85 · 2025: $23.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $237.48 | 2021-2022 | |
| Incyte Corporation | $170.97 | 2021-2022 | |
| Seagen INC. | $147.91 | 2021-2023 | Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $147.82 | 2021-2022 | |
| Amgen INC. | $105.48 | 2021-2022 | |
| Karyopharm Therapeutics INC. | $75.33 | 2022 | |
| Janssen Scientific Affairs, LLC | $71.86 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $71.10 | 2022 | |
| Adc Therapeutics America, INC. | $64.31 | 2021-2022 | |
| Epizyme, INC. | $53.87 | 2021-2022 | |
| Abbvie INC. | $46.17 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $42.13 | 2022 | |
| Jazz Pharmaceuticals INC. | $35.66 | 2022 | |
| Morphosys, US INC. | $34.25 | 2022-2023 | Monjuvi |
| Glaxosmithkline, LLC. | $27.64 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $21.97 | 2022 | |
| Stemline Therapeutics INC. | $15.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Teaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.